Minimum Effective Volume Of Local Anesthetic İn USG Guided Axillary Approach Brachial Plexus Block
1 other identifier
interventional
55
0 countries
N/A
Brief Summary
Background Peripheral nerve blocks with use of USG allowed visualisation of the structures and nerves and made the block administrations safe, quick and comfortable. However there are few publications concerning the minimum local anesthetic volume capable of providing blocks. In this study the investigastors aimed to find Minimum Effective Volume Of Local Anesthetic For Ultrasound-Guided Axillary Brachial Plexus Block in hand, elbow and forehand operations. Materials \& Methods A total of 55 ASA I-II patients underwent hand surgery operation by administering USG guided-axillary brachial plexus blockage were included in the study. Ulnar, median and radial nerves were seen and the minimum effective local anesthetic volume was investigated starting with total 21 ml of %0.5 bupivacain. After accomplishing the blockage, volume was decreased by 0.5 for each nerves. Block administration time, block onset times, anesthesia times and time to first analgesic requirement were recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Dec 2014
Shorter than P25 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 17, 2016
CompletedFirst Posted
Study publicly available on registry
July 20, 2016
CompletedJanuary 13, 2020
December 1, 2018
4 months
January 17, 2016
January 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Minimum effective volume of bupivacain %0.5
Ulnar, median and radial nerves were seen and the minimum effective local anesthetic volume was investigated starting with total 21 ml of %0.5 bupivacain. After accomplishing the blockage, volume was decreased by 0.5 for each nerves
1 hour
Secondary Outcomes (1)
first analgesic requirement
1 day (0,1, 2, 4, 6, 8, 10, 12, 18, 24 hours)
Study Arms (1)
Bupivacaine 0,5% Single arm study
OTHERBupivacaine 0,5% Single arm study
Interventions
Bupivacaine 0,5% The study method was a step-up/step-down sequence model where the dose for following patients was determined by the outcome of the preceding block. The starting dose of bupivacaine was 5 mL per nerve. In the case of block failure, the dose was increased by 0.5 mL per nerve. Conversely, block success resulted in a reduction in dose by 0.5 mL per nerve. Each of the three nerves was treated as a separate entity. Dose adjustments were made to each nerve individually. The volume dose was increased in 0.5 mL at every 5 consecutive cases regardless of the result of the previous block in order to minimize bias occurence. A blinded assistant assessed sensory and motor blockade at 5-min intervals up to 30 min.
Eligibility Criteria
You may qualify if:
- were age over 18 and under 65 years
- informed consent (IC) signed by the patient
- indication for brachial plexus block (anesthesia and analgesia) in candidates forelective hand surgery
- ASA physical status I or II according to the American Society of Anesthesiologists
- body mass index (BMI) \<35 kg/m2.
You may not qualify if:
- Cognitive impairment or active psychiatriccondition
- İnfection at the blockade puncture site
- Bleeding disorders
- History of local anesthetic allergy
- Pregnancy
- The patients does not want this method .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
January 17, 2016
First Posted
July 20, 2016
Study Start
December 1, 2014
Primary Completion
April 1, 2015
Study Completion
August 1, 2015
Last Updated
January 13, 2020
Record last verified: 2018-12